Cannabichromevarin

Cannabichromevarin (CBCV) is a cannabinoid found in the Cannabis plant. It is a homolog of cannabichromene (CBC), with the side-chain shortened by two methylene bridges. CBCV is a non-psychoactive cannabinoid, meaning it does not produce the "high" associated with certain strains of cannabis.
Chemistry[edit]
CBCV is a phytocannabinoid, which are cannabinoids produced by plants. It is structurally similar to other phytocannabinoids, with a 21-carbon structure. The chemical formula of CBCV is C19H26O2. Like other cannabinoids, CBCV is lipophilic, meaning it dissolves in fats and oils.
Biosynthesis[edit]
The biosynthesis of CBCV in the cannabis plant begins with the production of geranyl pyrophosphate and olivetolic acid, which are combined to form cannabigerovarin acid (CBGVA). This compound is then converted into cannabichromevarin acid (CBCVA) by the enzyme CBCVA synthase. Finally, CBCVA is decarboxylated, usually through heat, to produce CBCV.
Pharmacology[edit]
The pharmacological effects of CBCV are not well-studied. However, it is known that CBCV does not bind strongly to the CB1 receptor or the CB2 receptor, the main targets of the psychoactive cannabinoid THC. This is why CBCV does not produce a "high". Some research suggests that CBCV may have anti-inflammatory and analgesic effects, but more studies are needed to confirm these findings.
Legal status[edit]
The legal status of CBCV varies by country and sometimes by state or province. In many places, it is legal to possess and use CBCV, but it is often regulated under cannabis laws.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
